PACS Group (PACS) Competitors $16.50 -0.05 (-0.30%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PACS vs. HIMS, GH, OPCH, SHC, BTSG, VCYT, SGRY, LFST, CON, and PRVAShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. PACS Group vs. Hims & Hers Health Guardant Health Option Care Health Sotera Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group Concentra Group Holdings Parent Privia Health Group Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment. Is HIMS or PACS more profitable? Hims & Hers Health has a net margin of 8.19% compared to PACS Group's net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% PACS Group N/A N/A N/A Do analysts recommend HIMS or PACS? Hims & Hers Health presently has a consensus target price of $20.71, indicating a potential downside of 18.22%. PACS Group has a consensus target price of $39.88, indicating a potential upside of 141.67%. Given PACS Group's stronger consensus rating and higher possible upside, analysts plainly believe PACS Group is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38PACS Group 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of HIMS or PACS? 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable valuation and earnings, HIMS or PACS? PACS Group has higher revenue and earnings than Hims & Hers Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$872M6.35-$23.55M$0.4457.57PACS Group$3.56B0.71$112.87MN/AN/A Does the MarketBeat Community believe in HIMS or PACS? Hims & Hers Health received 16 more outperform votes than PACS Group when rated by MarketBeat users. However, 100.00% of users gave PACS Group an outperform vote while only 37.37% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes3737.37% Underperform Votes6262.63% PACS GroupOutperform Votes21100.00% Underperform VotesNo Votes Does the media refer more to HIMS or PACS? In the previous week, PACS Group had 35 more articles in the media than Hims & Hers Health. MarketBeat recorded 64 mentions for PACS Group and 29 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.47 beat PACS Group's score of 0.09 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 9 Very Positive mention(s) 6 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral PACS Group 7 Very Positive mention(s) 4 Positive mention(s) 45 Neutral mention(s) 6 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryHims & Hers Health beats PACS Group on 8 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupSkilled nursing care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$2.52B$3.23B$5.38B$20.16BDividend YieldN/A1.07%5.14%3.50%P/E RatioN/A15.85105.9744.52Price / Sales0.711.201,246.6917.75Price / CashN/A15.7140.3421.28Price / BookN/A3.387.084.71Net Income$112.87M$98.56M$119.65M$986.85M7 Day Performance-5.17%-0.64%2.15%3.73%1 Month Performance-59.81%-13.89%-3.13%3.70%1 Year PerformanceN/A17.43%33.79%27.73% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group4.0956 of 5 stars$16.50-0.3%$39.88+141.7%N/A$2.52B$3.56B0.0032,433High Trading VolumeHIMSHims & Hers Health3.6169 of 5 stars$23.94+9.8%$20.71-13.5%+213.1%$5.23B$872M54.401,046Analyst ForecastInsider TradeHigh Trading VolumeGHGuardant Health3.9877 of 5 stars$31.09+1.3%$40.60+30.6%+40.6%$3.84B$563.95M-7.311,779OPCHOption Care Health4.9817 of 5 stars$22.46+2.7%$30.83+37.3%-23.3%$3.82B$4.30B18.397,802Positive NewsSHCSotera Health4.2362 of 5 stars$12.41-6.1%$16.50+33.0%-6.6%$3.52B$1.05B51.483,000Analyst ForecastHigh Trading VolumeBTSGBrightSpring Health Services2.8925 of 5 stars$18.75-0.2%$16.79-10.4%N/A$3.26B$8.83B-72.0835,000Positive NewsVCYTVeracyte4.1662 of 5 stars$38.94-0.7%$41.25+5.9%+51.6%$3.02B$361.05M-261.33790SGRYSurgery Partners3.1211 of 5 stars$23.36+3.8%$38.71+65.7%-29.9%$2.97B$2.74B-46.9013,500Analyst ForecastLFSTLifeStance Health Group1.7824 of 5 stars$7.31+1.2%$8.50+16.3%+15.6%$2.80B$1.06B-28.129,325CONConcentra Group Holdings ParentN/A$21.48+1.0%$28.50+32.7%N/A$2.74B$1.88B0.0011,000PRVAPrivia Health Group3.3925 of 5 stars$21.18+1.9%$25.07+18.4%-2.8%$2.54B$1.66B211.771,102Positive News Related Companies and Tools Related Companies HIMS Alternatives GH Alternatives OPCH Alternatives SHC Alternatives BTSG Alternatives VCYT Alternatives SGRY Alternatives LFST Alternatives CON Alternatives PRVA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:PACS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.